Source:Biological Psychology, Volume 129
Author(s): Thomas Janssens, Thomas Ritz
http://ift.tt/2zUwxxM
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2ihTELJ
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2gST7iJ
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2iiNTxc
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2gSSUvX
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2ihTrrV
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
http://ift.tt/2gPdqh7
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
Author(s): Michelle Doll, Nadia Masroor, Yvette Major, Michele Fleming, Christopher Doern, Kaila Cooper, Michael Stevens, Gonzalo Bearman
Limited treatment options and a growing global threat from carbapenem-resistant Enterobacteriaceae (CRE) infections illustrate the importance of understanding the epidemiology of CRE. Using a retrospective chart review and point prevalence testing demonstrated specific patient risk factors for CRE-positive clinical cultures in a tertiary medical center with a low CRE prevalence.
http://ift.tt/2iiQUNX
Publication date: 1 November 2017
Source:American Journal of Infection Control, Volume 45, Issue 11
Author(s): Yingying Hong, Peter J. Teska, Haley F. Oliver
This study investigated the influence of contact time and concentration on bactericidal efficacy of 3 types of disinfectants (accelerated hydrogen peroxide [AHP], quaternary ammonium compounds [Quats], and sodium hypochlorite) on stainless steel surfaces using Environmental Protection Agency procedure MB-25-02. We found that bactericidal efficacy was not reduced at contact times or concentrations immediate lower than label use values, but all 3 disinfectants were significantly less bactericidal at significantly lower than label use contact times and concentrations. Overall, the bactericidal efficacy of the sodium hypochlorite disinfectant was most tolerant to the decreases of contact times and concentrations, followed closely by AHP disinfectant, and Quat disinfectant was most affected by contact time and concentration.
http://ift.tt/2gQUPRX
Trastuzumab with fluoropyrimidine and cisplatin is the standard first-line treatment in patients with HER2-positive advanced gastro-esophageal adenocarcinoma. However, there are no safety and efficacy data of trastuzumab with FOLFIRI.
To evaluate safety and efficacy of FOLFIRI plus trastuzumab in patients with HER2-positive advanced gastro-esophageal adenocarcinoma.
This retrospective multicenter study included all consecutive patients with HER2-positive advanced gastro-esophageal adenocarcinoma treated with FOLFIRI plus trastuzumab between 2012 and 2015.
A total of 33 patients (median age, 60.3; performance status 0–1, 78.8%) with HER2-positive advanced gastro-esophageal adenocarcinoma treated with FOLFIRI plus trastuzumab in first (n = 3), second (n = 20) or third (n = 10) line of chemotherapy were included. There was one case of a severe non-hematological adverse event corresponding to a left ventricular systolic dysfunction. The most common hematological grade 3 or 4 adverse events were neutropenia (12.9%) and thrombocytopenia (6.4%). There was no febrile neutropenia. For patients treated with FOLFIRI plus trastuzumab in second-line chemotherapy, the median overall survival was 9.5 months.
This is the first western population-based study of FOLFIRI plus trastuzumab reporting a satisfactory safety profile and a potential efficacy in advanced HER2-positive gastric cancer.